TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in distance in 6-min walking test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to the first defibrillation attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to the 2018 AHA pVT algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incorrect shock or drug doses
Endpoint domain: Adverse events/effects
Primary endpoint: Disease Management (DM)
Endpoint domain: Mortality/survival
Primary endpoint: PTA incidence
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in last-day-test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant satisfaction with teaching methods
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Progression-Free Survival (PFS) benefit
Endpoint domain: Mortality/survival
Primary endpoint: Reimbursement acceptance rate
Endpoint domain: Resource use
Primary endpoint: Five-year progression free survival
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in peak total bile acid concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Increase in ascending colon half-emptying time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Quality of diet (mAHEI scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total stone removal rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Graft preparation failure rate
Endpoint domain: Adverse events/effects
Primary endpoint: journal club attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: AUC for CHD prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity for CHD prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity for CHD prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cessation medication use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal intubation rate
Endpoint domain: Adverse events/effects
Primary endpoint: Patient-reported function improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dynamic knee valgus reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged quadriceps motor block
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in serum tumor necrosis factor alpha (TNF‐α)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stroke or death at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Kidney composite outcome risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cardiovascular composite outcome incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: plasma NOx levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: triglycerides levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Impact bias for health outcomes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: composite outcome rate at 60 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patients' PSP capability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intention to stop khat chewing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Understandable explanations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Demonstrating empathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Building trust
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: caregiver strain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: disabling stroke rate
Endpoint domain: Adverse events/effects
Primary endpoint: EoE Endoscopic Reference Score total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysphagia frequency improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Seroprotection rate after third vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: rsFC interaction in the PUCN on DMN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rsFC interaction in the orbIFG.L on SN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FVIII trough levels deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: percent heavy drinking or drug use days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in perception of health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to initial ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-24h of ≥ 400 mg × h/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fall efficacy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Instrumental ADL performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: reduction in adductor tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: NfL levels in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle synthesis (Rdphe)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: muscle breakdown (Raphe)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Upper intermolar width
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: subendocardial viability ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HBsAg levels drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: HBsAg ≤ 100 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: HBV DNA undetectable
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Change in exercise endurance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting hyperinflation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Perceived benefit of NIV on breathlessness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in pain at week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention in treatment at week 24
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: trait mindfulness enhancement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Skill
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time-to-first severe COPD exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Leg volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ejection fraction rate (EF%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postural outcomes (pelvic tilt, pelvic torsion, lordotic angle)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: High sensitive C-reactive protein (hsCRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HbA1c mean baseline change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adverse events risk
Endpoint domain: Adverse events/effects
Primary endpoint: Engagement of patients and providers in care improvement opportunities for prediabetes
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Urinary KIM-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: MCP-1/Cr
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Preferences for screening tests
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of positive stress tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biofilm removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pull-out strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation scores (OAA/S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score of obsession and compulsion subscales of Y-BOCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One-year tumor-death censored graft survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of attempts of needle insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of insomnia-free nights
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Decreases in haemoglobin and platelet count
Endpoint domain: Adverse events/effects
Primary endpoint: Cervical Th17-like cells frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: anti-HBs titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: seroprotection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FAOS (Foot and Ankle Outcome Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of vasovagal reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Greater donor confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: opioid escape medication use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total HF hospitalizations and CV death
Endpoint domain: Mortality/survival
Primary endpoint: Shoulder function (SPADI scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attribution of cause of the disease to risk factors and immunity factors (IPQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dependency of nicotine (FTND)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of Lactobacilli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescribing errors, omissions and discrepancies
Endpoint domain: Adverse events/effects
Primary endpoint: Documentation of adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Guideline concordance in VTE risk assessment and prescribing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perioperative mortality risk adjustment
Endpoint domain: Mortality/survival
Primary endpoint: Decreased LSMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total amount of milk production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total systemic exposure (AUC0‐6 and AUC0‐24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absorption rate (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of depth of COS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arch length and width increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PSQI remission rate
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: HAMD‐17 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dental caries in permanent or deciduous teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Detectable viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: functional dwell time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: post-insertion failure
Endpoint domain: Adverse events/effects
Primary endpoint: Sympathetic tonus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Parasympathetic tonus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Viremia detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: incidence and degree of intraoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clarity of operative field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in emotional regulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mood stability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sustained temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: day 28 PCR-corrected efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: number needed to excise reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: benign to malignant ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BTC-specific death
Endpoint domain: Mortality/survival
Primary endpoint: time to extubate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: immediate memory improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: recovery time for consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in pain variables and discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence in AI results
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nurses' performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shear modulus of the multifidus muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total serum bilirubin reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage decrease in bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage reduction in seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Risk of events during intervention condition
Endpoint domain: Adverse events/effects
Primary endpoint: quality of life (SF-36 score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: fear/avoidance symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depressive state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive changes in GAS score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean increase in eGFR readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Current pain (visual analog scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average pain over 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fixation time on neutral faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fixation count on happy faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean visual gain from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean decrease in central subfield macular thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of injections in 2 years
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Testing uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Demand for ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmatory testing for newly diagnosed HIVST positive participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily mean opioid usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: subjective appearance distortion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: stress induced by exposure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk categorization based on PSA testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IVCM improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of neurosphere formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sitting balance and trunk function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ablation attempt number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement of skin barrier and morphological properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Increased skin hydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Decreased sebum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prevalence of wheeze and rhinitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: immediate stone-free rate (SFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bleeding-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Pain rates by VAS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain rates in McGill's questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower anxiety symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: longer patient-physician conversations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in pain score using Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour mediastinal drain loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant early postoperative bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: RMDQ scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of PLWDs in POAG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of observed disc hemorrhage in POAG with PLWDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of lamina cribrosa defects in POAG with PLWDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total fluorescein staining score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decisional conflict scores reduction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physical aspects of quality of life score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cytokine levels (CCL19, CXCL10, TNF-α, etc.)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Systemic Lupus Erythematosus Disease Activity Index-2000
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tender and swollen joint count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bone area percent of newly formed bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking cessation after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NOSE score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Inspiratory total nasal resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: sweating sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mobility of hands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: comfort wearing experience
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning